Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Advanced Pharmaceutical Bulletin|December 10, 2021
miR-146a-5p and miR-193a-5p Synergistically Inhibited the Proliferation of Human Colorectal Cancer Cells (HT-29 cell line) through ERK Signaling PathwaySaeed Noorolyai, Elham Baghbani, Dariush Shanehbandi, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|September 25, 2017
Nano-delivery system targeting to cancer stem cell cluster of differentiation biomarkersAhad Mokhtarzadeh, Soodabeh Hassanpour, Zahra Farajzadeh Vahid, et al.Human Immunology|May 22, 2021
The impact of microRNAs on myeloid-derived suppressor cells in cancerElham Baghbani, Saeed Noorolyai, Pascal H G Duijf, et al.Pathology, Research and Practice|November 12, 2022
Silencing of SiX-4 enhances the chemosensitivity of melanoma cells to CisplatinAysan Fallah Vazirabad, Saeed Noorolyai, Elham Baghbani, et al.Clinical Nutrition (Edinburgh, Scotland)|April 12, 2022
Immunomodulatory and clinical responses to zinc gluconate supplementation in patients with Behçet's disease: A double-blind, randomized placebo-controlled clinical trialAmir Hossein Faghfouri, Alireza Khabbazi, Behzad Baradaran, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 4, 2021
Silencing tumor-intrinsic CD73 enhances the chemosensitivity of NSCLC and potentiates the anti-tumoral effects of cisplatin: An in vitro studyElham Baghbani, Saeed Noorolyai, Shima Rahmani, et al.BMC Research Notes|December 30, 2020
Epigenetic mechanisms shape the underlining expression regulatory mechanisms of the STAT3 in multiple sclerosis diseaseArezoo Hosseini, Zohreh Babaloo, Tohid Gharibi, et al.Gene|October 17, 2020
The expression analyses of RMRP, DDX5, and RORC in RRMS patients treated with different drugs versus naïve patients and healthy controlsShima Rahmani, Saeed Noorolyai, Hormoz Ayromlou, et al.Life Sciences|July 15, 2021
Regulation of immune responses through CD39 and CD73 in cancer: Novel checkpointsElham Baghbani, Saeed Noorolyai, Dariush Shanehbandi, et al.Pageof 2